A peanut allergy is an immune system overreaction in which your body mistakenly treats peanut proteins as a dangerous invader, triggering symptoms that can range from mild hives to life-threatening anaphylaxis. It affects an estimated 6.2 million children and adults in the United States, and its prevalence has climbed sharply: roughly 3 percent of U.S. adults had a peanut allergy in 2015-2016, compared to less than 1 percent in 1999. Peanut is one of the most common food allergens in both children and adults, and unlike some childhood food allergies, many people never outgrow it.
How Your Immune System Creates the Reaction
Under normal circumstances, your immune system produces a type of antibody called IgE to flag genuinely harmful invaders like parasites. In people with a peanut allergy, the immune system mislabels one or more peanut proteins as dangerous. The first time this happens, your body quietly produces IgE antibodies specific to that peanut protein. You won’t feel a thing during this “sensitization” phase.
The trouble starts with the next exposure. When you eat peanut again, those IgE antibodies recognize the protein, latch onto it, and signal your body to flood your system with histamine and other inflammatory chemicals. Because IgE circulates throughout your bloodstream, this reaction isn’t limited to your stomach. It can hit your skin, lungs, throat, heart, and gut all at once, which is what makes peanut allergy potentially so dangerous compared to, say, a food intolerance that stays in the digestive tract.
Symptoms From Mild to Severe
Reactions typically begin within minutes of eating peanut, though they can sometimes take up to two hours. Mild to moderate symptoms include:
- Hives, redness, or swelling on the skin
- Itching or tingling in or around the mouth and throat
- Stomach cramps, nausea, vomiting, or diarrhea
- Runny nose or wheezing
The most serious reaction is anaphylaxis, which can involve tightening of the airways, swelling of the tongue and throat severe enough to block breathing, a dangerous drop in blood pressure, rapid pulse, dizziness, and loss of consciousness. Anaphylaxis can be fatal without immediate treatment. Not every reaction will progress to anaphylaxis, and the severity of one reaction doesn’t reliably predict the next. Someone who previously had only hives can still experience anaphylaxis on a future exposure.
How Peanut Allergy Is Diagnosed
No single test confirms a peanut allergy with absolute certainty, so allergists typically combine multiple tools. A skin prick test involves placing a tiny amount of peanut protein on the skin (usually the forearm or back) and pricking the surface with a sterile probe. If a small bump resembling a mosquito bite appears within 15 to 30 minutes, the test is considered positive. The size of the bump does not predict how severe a real reaction would be.
Blood tests measure the level of peanut-specific IgE antibodies. Results come back in one to two weeks and are reported as a number, but like the skin test, a higher number doesn’t necessarily mean a worse reaction. Both tests can show sensitization (your body has made IgE against peanut) without true clinical allergy, which is why a history of actual symptoms matters so much in the diagnosis.
When skin and blood tests are inconclusive, the gold standard is an oral food challenge. Under close medical supervision, you eat gradually increasing amounts of peanut while an allergist monitors for any reaction. This is the most definitive way to confirm or rule out the allergy.
Cross-Reactivity With Other Foods
Peanuts are legumes, not tree nuts, which means they’re in the same botanical family as soybeans, lentils, chickpeas, and lupine. Your immune system can sometimes recognize similar proteins across these foods, a phenomenon called cross-reactivity. Lab studies have found that cross-sensitization between peanut and tree nuts can be detected in up to 86 percent of peanut-allergic individuals. That sounds alarming, but it’s misleading: the rate of actual clinical reactions to those foods is much lower than the rate of positive test results. Many people test “sensitive” to a related food on paper but eat it without any problem.
The most clinically relevant cross-reactions tend to be between peanut and lupine (a flour increasingly used in European baking), peanut and soy, and among chickpea and lentil. Geography and diet play a role; if a food is commonly eaten in your region, cross-reactivity is more likely to show up. Your allergist can help you figure out which related foods you actually need to avoid rather than unnecessarily restricting your diet based on lab results alone.
Reading Food Labels
U.S. law requires food manufacturers to clearly identify peanut as an ingredient whenever it’s present. You’ll see this in one of two ways: either in parentheses next to an ingredient name (for example, “arachis oil (peanut)”) or in a separate “Contains” statement at the end of the ingredient list. If a “Contains” statement appears, it must list every major allergen in the product, so checking that line is a quick screening method.
The trickier issue is cross-contact during manufacturing. Some products carry voluntary advisory statements like “may contain peanuts” or “produced in a facility that processes peanuts.” These labels warn that trace amounts of peanut could have ended up in the product through shared equipment. The key word is “voluntary.” Not all manufacturers use these statements, so the absence of a “may contain” warning doesn’t guarantee the product is free from trace peanut exposure. For people with severe allergies, contacting the manufacturer directly is sometimes the safest approach.
Emergency Treatment With Epinephrine
Epinephrine (commonly carried as an auto-injector like an EpiPen) is the first-line treatment for anaphylaxis. It works by reversing the most dangerous effects of the reaction: it opens the airways, raises blood pressure, and reduces swelling. Speed matters. The sooner it’s administered, the more effective it is.
Auto-injectors come in two strengths based on body weight. Children weighing 15 to 30 kg (roughly 33 to 66 pounds) use the junior dose. Anyone 30 kg (about 66 pounds) or heavier uses the standard dose. The injection goes into the outer thigh and can be given through clothing. After injecting, hold the device in place for three seconds, then massage the area for about 10 seconds. A second injection may be needed if symptoms don’t improve or return before help arrives. Emergency medical care is always necessary after using epinephrine, even if symptoms seem to resolve.
Oral Immunotherapy
In 2020, the FDA approved the first oral immunotherapy product specifically for peanut allergy. It works by giving patients tiny, carefully measured doses of peanut protein daily, gradually increasing the amount over months. The goal is not to cure the allergy but to raise the threshold at which a reaction occurs, so that accidental exposure to a small amount of peanut is less likely to cause a severe reaction. Treatment can begin in children as young as 1 year old, with initial dose escalation approved for patients through age 17. The daily maintenance dose is 300 mg of peanut protein.
This therapy requires ongoing daily dosing to maintain its protective effect, and patients still need to carry epinephrine and avoid peanut in their diet. Allergic reactions during treatment are common, which is why the initial doses are given in a medical setting. It’s a meaningful option for reducing the risk of accidental reactions, but it’s not a free pass to eat peanut butter sandwiches.
Preventing Peanut Allergy in Infants
Guidelines from the National Institute of Allergy and Infectious Diseases changed the conversation around peanut allergy prevention. For decades, parents were told to delay introducing peanut. The current recommendations flip that approach entirely, based on landmark research showing that early introduction reduces allergy risk.
The guidelines break infants into three groups. High-risk infants (those with severe eczema, egg allergy, or both) should be introduced to age-appropriate peanut-containing foods as early as 4 to 6 months. These babies may benefit from allergy testing before that first taste. Infants with mild to moderate eczema should try peanut-containing foods around 6 months. Infants with no eczema or existing food allergies can have peanut introduced freely alongside other solid foods, whenever the family is ready. In all cases, other solid foods should be introduced first to confirm the baby is developmentally ready to eat.
For young infants, “peanut-containing food” doesn’t mean whole peanuts, which are a choking hazard. Thinned peanut butter mixed into a puree or dissolved peanut puff snacks are common starting options.